Global Personalized mRNA Cancer Vaccine Therapy Market
According to a new report from Intel Market Research, the global Personalized mRNA Cancer Vaccine Therapy market was valued at USD 1,230 million in 2024 and is projected to reach USD 1,860 million by 2032, growing at a steady CAGR of 7.0% during the forecast period (2025–2032). This growth is driven by advancements in precision medicine, rising cancer prevalence, and the increasing...
0 Yorumlar 0 hisse senetleri 23 Views 0 önizleme